Nutritional and Exercise Lab University of Wyoming
Laramie, Wyoming, 82071, United States
NCT Number: NCT01514539
Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk Studies suggest that childbearing is an important contributor to the development of obesity in many women and that breastfeeding may be protective.
Ghrelin and peptide YY (PYY) are gut hormones involved in appetite regulation and energy homeostasis and are biological neuroendocrine signals that potentially affect body weight and adiposity/
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Laramie, Wyoming, 82071, United States
Role of Ghrelin and PYY in Postpartum Body Weight Regulation and Presence in Human Milk.
This study evaluated whether fasting or postprandial ghrelin or PYY is different between lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Eligibility Criteria: Healthy females, 18+ years old, non-smokers, no major food allergies, first-time mom, currently pregnant or within 1 month of giving birth.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monitoring two recently discovered appetite hormones called "ghrelin" and "neuropeptide YY (PYY)." This study evaluated whether fasting or postprandial ghrelin or PYY is different btween lactating and nonlactating postpartum women matched for age, body weight, and adiposity.
Time frame: 5 years
Biomedical Research Study that will provide information on reducing maternal obesity.
University of Wyoming
Other
Role of Ghrelin and PYY in Postpartum Body Weight Regulation and Presence in Human Milk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06402825
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Sherbrooke, Quebec, Canada
View Trial DetailsNCT04991402
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Cape Town, South Africa
View Trial DetailsNCT07379307
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Tokat Province, Turkey (Türkiye)
View Trial DetailsNCT05473767
Body Weight, Cardiovascular Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details